Pieris Pharmaceuticals (PIRS) EPS Estimated At $0.52; Maiden Holdings, Ltd. (MHLD) Covered By 1 Bulls

Among 4 analysts covering Maiden Holdings (NASDAQ:MHLD), 1 have Buy rating, 1 Sell and 2 Hold. Therefore 25% are positive. Maiden Holdings had 7 analyst reports since August 6, 2015 according to SRatingsIntel. Zacks upgraded Maiden Holdings, Ltd. (NASDAQ:MHLD) on Tuesday, August 25 to “Sell” rating. The stock of Maiden Holdings, Ltd. (NASDAQ:MHLD) has “Buy” rating given on Wednesday, February 24 by Compass Point. Zacks downgraded the stock to “Sell” rating in Wednesday, September 2 report. The stock of Maiden Holdings, Ltd. (NASDAQ:MHLD) has “Mkt Perform” rating given on Monday, November 28 by FBR Capital. As per Wednesday, January 4, the company rating was downgraded by Compass Point. The rating was reinitiated by Keefe Bruyette & Woods on Tuesday, January 31 with “Outperform”. See Maiden Holdings, Ltd. (NASDAQ:MHLD) latest ratings:

31/01/2017 Broker: Keefe Bruyette & Woods Rating: Outperform Reinitiate
04/01/2017 Broker: Compass Point Old Rating: Buy New Rating: Neutral Downgrade
28/11/2016 Broker: FBR Capital Old Rating: Outperform New Rating: Mkt Perform Downgrade

Analysts expect Pieris Pharmaceuticals Inc (NASDAQ:PIRS) to report $0.52 EPS on May, 10.They anticipate $0.62 EPS change or 620.00% from last quarter’s $-0.1 EPS. PIRS’s profit would be $34.24 million giving it 1.82 P/E if the $0.52 EPS is correct. After having $-0.16 EPS previously, Pieris Pharmaceuticals Inc’s analysts see -425.00% EPS growth. About 3.15 million shares traded or 200.00% up from the average. Pieris Pharmaceuticals Inc (NASDAQ:PIRS) has risen 114.62% since September 27, 2016 and is uptrending. It has outperformed by 104.05% the S&P500.

About 78,670 shares traded. Maiden Holdings, Ltd. (NASDAQ:MHLD) has declined 5.44% since September 27, 2016 and is downtrending. It has underperformed by 16.00% the S&P500.

Maiden Holdings, Ltd. is a holding company. The company has market cap of $1.02 billion. The Firm focuses on serving the needs of regional and specialty insurers in the United States, Europe and select other global markets by providing reinsurance solutions designed to support their capital needs. It has a 66.45 P/E ratio. It operates through two divisions: Diversified Reinsurance and AmTrust Reinsurance.

Investors sentiment decreased to 0.99 in 2016 Q4. Its down 1.01, from 2 in 2016Q3. It is negative, as 28 investors sold Maiden Holdings, Ltd. shares while 57 reduced holdings. 27 funds opened positions while 57 raised stakes. 57.49 million shares or 1.14% less from 58.15 million shares in 2016Q3 were reported. 4.53M are owned by Boston Prtn. Blackrock Grp, United Kingdom-based fund reported 140,942 shares. Hancock Holdings holds 61,030 shares or 0.04% of its portfolio. Piermont Cap Mgmt Inc, a Missouri-based fund reported 176,618 shares. Group One Trading Lp invested in 0% or 1,452 shares. Guggenheim Limited Liability Corp holds 0.03% or 550,575 shares. Citigroup reported 0% in Maiden Holdings, Ltd. (NASDAQ:MHLD). Comerica State Bank holds 77,781 shares or 0.01% of its portfolio. Us Bankshares De reported 7,969 shares. Credit Agricole S A holds 0.01% of its portfolio in Maiden Holdings, Ltd. (NASDAQ:MHLD) for 171,685 shares. Manufacturers Life Insur The reported 45,475 shares. National Bank & Trust Of Montreal Can holds 0.01% of its portfolio in Maiden Holdings, Ltd. (NASDAQ:MHLD) for 312,529 shares. Naples Global Advisors Limited Liability owns 64,188 shares. State Of Alaska Department Of Revenue has invested 0.01% of its portfolio in Maiden Holdings, Ltd. (NASDAQ:MHLD). Parkside Financial Bank And Tru stated it has 2,705 shares or 0.02% of all its holdings.

Since November 7, 2016, it had 0 buys, and 7 selling transactions for $2.43 million activity. The insider Haveron Patrick J sold $166,500. The insider METZ LAWRENCE F. sold 2,000 shares worth $35,290. On Tuesday, November 15 Highet Thomas sold $32,536 worth of Maiden Holdings, Ltd. (NASDAQ:MHLD) or 2,000 shares. $880,364 worth of stock was sold by NEFF RAYMOND MICHAEL on Wednesday, December 14. RASCHBAUM ARTURO MANUEL sold $956,200 worth of stock. Shares for $319,700 were sold by SCHMITT KAREN on Friday, November 11.